Immunotech Biopharm Ltd.
Immunotech Biopharm Ltd develops next‑generation T‑cell immunotherapies in China, with its flagship EAL in Phase III for post‑surgical liver cancer recurrence and a pipeline of CAR‑T, TCR‑T and niche products targeting high‑margin solid and hematologic malignancies.
Headquarters: China (CHN)
- Website: Visit Site 🔗
- Type: Corporation
Company Profile
- Sector: Hospitals and Health Care
- Industry: Medical Practices
- Employees: 173
- HQ: Beijing
Unlock the full potential.
Upgrade
Get access to Relative P/E Ratio Valuation Histogram.